178 related articles for article (PubMed ID: 38447930)
1. Is calcitonin gene-related peptide (CGRP) the missing link in food histamine-induced migraine? A review of functional gut-to-trigeminovascular system connections.
de Mora F; Messlinger K
Drug Discov Today; 2024 Apr; 29(4):103941. PubMed ID: 38447930
[TBL] [Abstract][Full Text] [Related]
2. A new era for migraine: The role of calcitonin gene-related peptide in the trigeminovascular system.
Chen ST; Wu JW
Prog Brain Res; 2020; 255():123-142. PubMed ID: 33008504
[TBL] [Abstract][Full Text] [Related]
3. CGRP and the Trigeminal System in Migraine.
Iyengar S; Johnson KW; Ossipov MH; Aurora SK
Headache; 2019 May; 59(5):659-681. PubMed ID: 30982963
[TBL] [Abstract][Full Text] [Related]
4. The Trigeminovascular Pathway: Role of CGRP and CGRP Receptors in Migraine.
Edvinsson L
Headache; 2017 May; 57 Suppl 2():47-55. PubMed ID: 28485848
[TBL] [Abstract][Full Text] [Related]
5. [Pathophysiological role of calcitonin gene-related peptide (CGRP) in migraine and cluster headache].
Meßlinger K
Schmerz; 2020 Apr; 34(2):181-187. PubMed ID: 32103345
[TBL] [Abstract][Full Text] [Related]
6. [Calcitonin gene-related peptide: a key player neuropeptide in migraine].
Ramos-Romero ML; Sobrino-Mejia FE
Rev Neurol; 2016 Nov; 63(10):460-468. PubMed ID: 27819404
[TBL] [Abstract][Full Text] [Related]
7. Recognizing the role of CGRP and CGRP receptors in migraine and its treatment.
Edvinsson L; Warfvinge K
Cephalalgia; 2019 Mar; 39(3):366-373. PubMed ID: 29020807
[TBL] [Abstract][Full Text] [Related]
8. Anti-CGRP antibody galcanezumab modifies the function of the trigeminovascular nocisensor complex in the rat.
Friedrich N; Németh K; Tanner M; Rosta J; Dobos I; Oszlács O; Jancsó G; Messlinger K; Dux M
J Headache Pain; 2024 Jan; 25(1):9. PubMed ID: 38243174
[TBL] [Abstract][Full Text] [Related]
9. Calcitonin gene-related peptide and migraine.
Karsan N; Goadsby PJ
Curr Opin Neurol; 2015 Jun; 28(3):250-4. PubMed ID: 25887765
[TBL] [Abstract][Full Text] [Related]
10. CGRP as the target of new migraine therapies - successful translation from bench to clinic.
Edvinsson L; Haanes KA; Warfvinge K; Krause DN
Nat Rev Neurol; 2018 Jun; 14(6):338-350. PubMed ID: 29691490
[TBL] [Abstract][Full Text] [Related]
11. Gender aspects of CGRP in migraine.
Labastida-Ramírez A; Rubio-Beltrán E; Villalón CM; MaassenVanDenBrink A
Cephalalgia; 2019 Mar; 39(3):435-444. PubMed ID: 29082826
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of calcitonin gene-related peptide function: a promising strategy for treating migraine.
Durham PL
Headache; 2008 Sep; 48(8):1269-75. PubMed ID: 18808507
[TBL] [Abstract][Full Text] [Related]
13. CGRP mechanism antagonists and migraine management.
Karsan N; Goadsby PJ
Curr Neurol Neurosci Rep; 2015 May; 15(5):25. PubMed ID: 25790955
[TBL] [Abstract][Full Text] [Related]
14. Calcitonin gene-related peptide levels in tear fluid are elevated in migraine patients compared to healthy controls.
Kamm K; Straube A; Ruscheweyh R
Cephalalgia; 2019 Oct; 39(12):1535-1543. PubMed ID: 31603037
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical localization of the calcitonin gene-related peptide binding site in the primate trigeminovascular system using functional antagonist antibodies.
Miller S; Liu H; Warfvinge K; Shi L; Dovlatyan M; Xu C; Edvinsson L
Neuroscience; 2016 Jul; 328():165-83. PubMed ID: 27155150
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo Release of Calcitonin Gene-Related Peptide from the Trigeminovascular System in Rodents.
Rasmussen RH; Jansen-Olesen I; Kristensen DM; Christensen SL
J Vis Exp; 2022 May; (183):. PubMed ID: 35635478
[TBL] [Abstract][Full Text] [Related]
17. Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution.
Lennerz JK; Rühle V; Ceppa EP; Neuhuber WL; Bunnett NW; Grady EF; Messlinger K
J Comp Neurol; 2008 Mar; 507(3):1277-99. PubMed ID: 18186028
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide effects in the trigeminal system: pathophysiology and clinical relevance in migraine.
Messlinger K; Fischer MJ; Lennerz JK
Keio J Med; 2011; 60(3):82-9. PubMed ID: 21979827
[TBL] [Abstract][Full Text] [Related]
19. Targeting of calcitonin gene-related peptide action as a new strategy for migraine treatment.
Kuzawińska O; Lis K; Cessak G; Mirowska-Guzel D; Bałkowiec-Iskra E
Neurol Neurochir Pol; 2016; 50(6):463-467. PubMed ID: 27553188
[TBL] [Abstract][Full Text] [Related]
20. Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288.
Knight YE; Edvinsson L; Goadsby PJ
Neuropeptides; 1999 Feb; 33(1):41-6. PubMed ID: 10657470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
